You are here

Prices & Quotes - UK Markets - Advanced Oncotherapy (AVO)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 36.75p
Change Today:
-0.25p
Market Cap:
165.79m
Sector:
Health Care Equipment & Services

Advanced Oncotherapy raises 5.91m to advance 'LIGHT' system

By Josh White

Date: Friday 22 Jan 2021

LONDON (ShareCast) - (Sharecast News) - Proton therapy cancer treatment developer Advanced Oncotherapy announced an equity fundraise of 5.91m before expenses on Friday, to progress its 'LIGHT' system.
The AIM-traded firm said the fundraise was effected through a direct subscription with the company and a placing with clients of SI Capital for a total of 14,783,540 new ordinary shares at a price of 40p each.

It said the fundraise would contribute to progressing the LIGHT system assembly, documentation, verification and validation activities in order to achieve its aim of having its first LIGHT system fully operational with a 230MeV beam in 2021.

The issue price represented a discount of 2.1% to the average closing middle market price of an ordinary share over the past 30-day period.

Its board said the fundraise shares would represent about 4.2% of its share capital as enlarged by their issue.

In addition, a total of 17,500 new shares would be issued as non-cash consideration at the issue price in lieu of fees due to a financial adviser in connection with the subscription.

"We are pleased to announce this equity raise of 5.9m as we strive to ensure that our first commercial LIGHT system is fully operational during 2021," said chief executive officer Nicolas Serandour.

"This transaction will bolster our working capital at a lower cost of capital than if we were to draw down further on our Nerano Pharma debt facility at this time.

"Despite the impact of the Covid-19 pandemic, we remain on track to deliver a LIGHT system with a clinically relevant 230MeV beam in the second half of 2021, a key milestone in our ambition to democratise proton beam therapy as a treatment for cancer."

At 1311 GMT, shares in Advanced Oncotherapy were down 4.47% at 41.56p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AVO Market Data

Currency UK Pounds
Price 36.75p
Change Today -0.25p
52 Week High 47.50p
52 Week Low 30.50p
Volume 109,438
Shares Issued 451.13m
Market Cap 165.79m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Income
Not Available
Growth
Not Available
Price Chg 6m
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
Not Available

AVO Dividends

No dividends found

Trades for 26-Nov-2021

Time Volume / Share Price
16:10 1,884 @ 36.00p
12:26 25,000 @ 37.00p
12:26 25,000 @ 37.00p
11:27 1,100 @ 36.00p
10:36 698 @ 36.00p

AVO Key Personnel

CEO Nicolas Serandour